LigaChem Biosciences, Inc.

ACTIVE

大田广域市, South Koreawww.legochembio.comPublic147 employeesEstablished: 2006-05-01

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2006

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

71.4%

Phase 2

28.6%

Trial Status Distribution

Completed

71.4%

Recruiting

14.3%

Terminated

14.3%

Clinical Trials

Trials sponsored by this organization (14)

A Study to Evaluate Claudin 18.2-Directed ADC LCB02A in Advanced Solid Tumors

Phase 1

Recruiting

interventional

Aug 2026191 participants

Study to Evaluate the Efficacy of Delpazolid as Add-on Therapy in Refractory Mycobacterium Abscessus Complex

Phase 2

Completed

interventional

Jan 202424 participants

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Phase 1

Recruiting

interventional

Oct 2023300 participants

A Phase 2a Study, Effect of Vancomycin With vs Without Delpazolid (LCB01-0371) in Patients With MRSA Bacteremia

Phase 2

Terminated

interventional

Apr 202240 participants

PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE)

Phase 2

Completed

interventional

Oct 202176 participants

Trial to Evaluate Bioequivalence of LCB01-0371 in Different Batches

Phase 1

Completed

interventional

Jan 202125 participants

A Mass Balance Study of LCB01-0371 After a Single Oral LCB01-0371 Dose With a [14C]LCB01-0371-microtrace

Phase 1

Completed

interventional

Jun 20206 participants

A Phase II Clinical Study of LCB01-0371 to Evaluate the EBA, Safety and PK

Phase 2

Completed

interventional

Dec 201679 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations